Lack of genetic evidence that fatty liver disease predisposes to COVID-19
Financial support: This work was supported by project grants from Amgen and Sanofi-Aventis, the Swedish Research Council [Vetenskapsr ådet (VR), 2016-01527], the Swedish state under the Agreement between the Swedish government and the county councils (the ALF-agreement) [SU 2018-04276], the Novonordisk Foundation Grant for Excellence in Endocrinology [Excellence Project, 9321-430], the Swedish Diabetes Foundation [DIA 2017-205], the Swedish Heart Lung Foundation [20120533], the Wallenberg Academy Fellows from the Knut and Alice Wallenberg Foundation [KAW 2017.0203] (SR).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Luca Valenti, Oveis Jamialahmadi, Stefano Romeo Tags: Letter to the Editor Source Type: research
More News: Academies | Cardiology | COVID-19 | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Genetics | Government | Grants | Heart | Liver | Liver Disease | Sweden Health | Urology & Nephrology